Listen Now

Our Panel of Experts

Mark G. Kris, MD

Attending Physician, Thoracic Oncology Service, The William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Al B. Benson, III, MD, FACP, FASCO

Professor of Medicine, Associate Director for Cooperative Groups, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Eileen M. O'Reilly, MD

Associate Director, Clinical Research, David M. Rubenstein Center for Pancreatic Cancer, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Medical College of Cornell University

John P. Leonard, MD

Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Associate Dean for Clinical Research, Weill Cornell Medical College, Vice Chairman of Medicine for Clinical Research, Associate Director, Cancer Center, Chief, Lymphoma Service, Attending Physician, New York Presbyterian Hospital

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Attending Physician, Leukemia Service, Member, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Ruben A. Mesa, MD, FACP

Consultant Hematologist, Mayo Clinic in Arizona, Chair, Division of Hematology & Medical Oncology, Deputy Director, Mayo Clinic Cancer Center, Professor of Medicine, Mayo Clinic Cancer Center

Gregory A. Daniels, MD, PhD

Associate Clinical Professor of Medicine, University of California San Diego, Rebecca and John Moores Cancer Center

Brochure

You can download the brochure for this workshop(pdf)(87.1 KB)

Workshop Date

This workshop was originally recorded on June 14, 2016.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top